| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urine | 22 | 2020 | 65 | 6.560 |
Why?
|
| Stem Cells | 29 | 2023 | 314 | 6.400 |
Why?
|
| Mesenchymal Stem Cells | 23 | 2023 | 182 | 5.450 |
Why?
|
| Cell Differentiation | 32 | 2023 | 467 | 4.090 |
Why?
|
| Tissue Engineering | 25 | 2019 | 659 | 3.750 |
Why?
|
| Urinary Bladder | 23 | 2020 | 183 | 3.680 |
Why?
|
| Extracellular Matrix | 17 | 2020 | 243 | 3.430 |
Why?
|
| Urothelium | 16 | 2018 | 55 | 3.050 |
Why?
|
| Regeneration | 15 | 2020 | 170 | 3.000 |
Why?
|
| Muscle Development | 8 | 2020 | 49 | 2.760 |
Why?
|
| Cell Proliferation | 24 | 2022 | 602 | 2.500 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 6 | 2020 | 82 | 2.420 |
Why?
|
| Adult Stem Cells | 5 | 2020 | 25 | 2.310 |
Why?
|
| Animals | 80 | 2023 | 7569 | 2.130 |
Why?
|
| Imaging, Three-Dimensional | 12 | 2019 | 134 | 2.040 |
Why?
|
| Hydrogels | 6 | 2022 | 126 | 2.020 |
Why?
|
| Kidney Diseases, Cystic | 3 | 2021 | 13 | 1.940 |
Why?
|
| Kidney | 11 | 2023 | 520 | 1.930 |
Why?
|
| Humans | 119 | 2023 | 32798 | 1.780 |
Why?
|
| Cells, Cultured | 38 | 2020 | 820 | 1.730 |
Why?
|
| Tissue Scaffolds | 12 | 2020 | 421 | 1.640 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2020 | 947 | 1.590 |
Why?
|
| Stem Cell Transplantation | 12 | 2020 | 212 | 1.560 |
Why?
|
| Nephrostomy, Percutaneous | 4 | 2020 | 17 | 1.530 |
Why?
|
| Urinary Tract | 5 | 2020 | 22 | 1.510 |
Why?
|
| Biocompatible Materials | 8 | 2022 | 233 | 1.450 |
Why?
|
| Cell Culture Techniques | 10 | 2019 | 172 | 1.410 |
Why?
|
| Male | 77 | 2021 | 19641 | 1.400 |
Why?
|
| Ureteral Obstruction | 5 | 2022 | 28 | 1.360 |
Why?
|
| Erectile Dysfunction | 7 | 2020 | 50 | 1.350 |
Why?
|
| Adult | 41 | 2023 | 9560 | 1.290 |
Why?
|
| Neovascularization, Physiologic | 6 | 2020 | 111 | 1.290 |
Why?
|
| Endothelial Cells | 5 | 2020 | 197 | 1.210 |
Why?
|
| Kidney Neoplasms | 6 | 2023 | 205 | 1.170 |
Why?
|
| Exosomes | 3 | 2023 | 44 | 1.100 |
Why?
|
| Bone Marrow Cells | 5 | 2020 | 123 | 1.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2022 | 117 | 1.040 |
Why?
|
| Epithelial Cells | 7 | 2023 | 129 | 1.030 |
Why?
|
| Intestine, Small | 7 | 2017 | 40 | 1.020 |
Why?
|
| Urethra | 7 | 2021 | 100 | 0.980 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 98 | 0.980 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2020 | 192 | 0.970 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 112 | 0.940 |
Why?
|
| Disease Models, Animal | 19 | 2020 | 1012 | 0.940 |
Why?
|
| Laser Therapy | 6 | 2020 | 56 | 0.940 |
Why?
|
| Placenta | 3 | 2023 | 75 | 0.930 |
Why?
|
| Rats | 22 | 2020 | 1606 | 0.910 |
Why?
|
| Myocytes, Smooth Muscle | 7 | 2017 | 72 | 0.910 |
Why?
|
| Cell Separation | 6 | 2018 | 90 | 0.910 |
Why?
|
| Intestinal Mucosa | 7 | 2013 | 73 | 0.900 |
Why?
|
| Muscle, Smooth | 8 | 2013 | 69 | 0.890 |
Why?
|
| Heparin | 4 | 2020 | 70 | 0.870 |
Why?
|
| Female | 38 | 2023 | 20261 | 0.870 |
Why?
|
| Urology | 2 | 2014 | 31 | 0.830 |
Why?
|
| Body Fluids | 1 | 2023 | 8 | 0.810 |
Why?
|
| Wound Healing | 5 | 2022 | 188 | 0.810 |
Why?
|
| Chemical Warfare Agents | 1 | 2023 | 14 | 0.800 |
Why?
|
| Mustard Gas | 1 | 2023 | 8 | 0.800 |
Why?
|
| Mice | 21 | 2023 | 2511 | 0.800 |
Why?
|
| Collagen | 8 | 2022 | 219 | 0.800 |
Why?
|
| Cell Movement | 4 | 2022 | 171 | 0.800 |
Why?
|
| Mice, Nude | 11 | 2022 | 290 | 0.790 |
Why?
|
| Testis | 4 | 2020 | 65 | 0.790 |
Why?
|
| Middle Aged | 27 | 2021 | 12125 | 0.770 |
Why?
|
| Kidney Diseases | 6 | 2022 | 250 | 0.750 |
Why?
|
| Ureter | 2 | 2021 | 38 | 0.750 |
Why?
|
| Hyaluronic Acid | 3 | 2022 | 54 | 0.710 |
Why?
|
| Urinary Incontinence, Stress | 3 | 2017 | 66 | 0.700 |
Why?
|
| Hepatocytes | 2 | 2012 | 82 | 0.690 |
Why?
|
| Young Adult | 14 | 2020 | 2730 | 0.680 |
Why?
|
| Cysts | 1 | 2021 | 17 | 0.680 |
Why?
|
| Urinary Calculi | 2 | 2020 | 7 | 0.670 |
Why?
|
| Ossification, Heterotopic | 1 | 2021 | 20 | 0.670 |
Why?
|
| Myoblasts | 2 | 2017 | 37 | 0.660 |
Why?
|
| Organoids | 2 | 2020 | 98 | 0.660 |
Why?
|
| Diabetic Nephropathies | 2 | 2019 | 227 | 0.650 |
Why?
|
| Mastectomy | 1 | 2020 | 61 | 0.650 |
Why?
|
| Liver | 3 | 2012 | 492 | 0.640 |
Why?
|
| Epididymitis | 1 | 2020 | 1 | 0.640 |
Why?
|
| Testicular Diseases | 1 | 2020 | 2 | 0.640 |
Why?
|
| Infarction | 1 | 2020 | 6 | 0.640 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 46 | 0.640 |
Why?
|
| Calcinosis | 1 | 2021 | 146 | 0.640 |
Why?
|
| Luciferases | 1 | 2019 | 31 | 0.630 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 754 | 0.610 |
Why?
|
| Kidney Calices | 1 | 2019 | 4 | 0.600 |
Why?
|
| Diverticulum | 1 | 2019 | 11 | 0.590 |
Why?
|
| Laparoscopy | 1 | 2021 | 184 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2022 | 264 | 0.580 |
Why?
|
| Coculture Techniques | 10 | 2020 | 80 | 0.580 |
Why?
|
| Nanoparticles | 4 | 2022 | 56 | 0.580 |
Why?
|
| Collagen Type I | 3 | 2018 | 42 | 0.580 |
Why?
|
| SOXF Transcription Factors | 1 | 2018 | 3 | 0.570 |
Why?
|
| Child | 12 | 2020 | 2478 | 0.570 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2018 | 4 | 0.560 |
Why?
|
| Swine | 9 | 2018 | 216 | 0.560 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2011 | 20 | 0.560 |
Why?
|
| Transforming Growth Factor beta1 | 6 | 2022 | 27 | 0.550 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 70 | 0.550 |
Why?
|
| Nitric Oxide | 1 | 2018 | 111 | 0.550 |
Why?
|
| Cicatrix | 1 | 2018 | 39 | 0.550 |
Why?
|
| Multipotent Stem Cells | 2 | 2016 | 17 | 0.530 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 83 | 0.520 |
Why?
|
| Fibrosis | 8 | 2022 | 122 | 0.520 |
Why?
|
| Culture Media, Conditioned | 5 | 2018 | 47 | 0.510 |
Why?
|
| Adrenal Glands | 1 | 2016 | 4 | 0.510 |
Why?
|
| Tomography, Spiral Computed | 1 | 2016 | 19 | 0.510 |
Why?
|
| Cell Shape | 5 | 2020 | 28 | 0.510 |
Why?
|
| Reconstructive Surgical Procedures | 4 | 2020 | 198 | 0.500 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2016 | 16 | 0.500 |
Why?
|
| Rabbits | 7 | 2020 | 192 | 0.500 |
Why?
|
| Flow Cytometry | 5 | 2019 | 186 | 0.500 |
Why?
|
| Signal Transduction | 8 | 2022 | 686 | 0.500 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 116 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2020 | 754 | 0.490 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2023 | 116 | 0.490 |
Why?
|
| Osteogenesis | 6 | 2020 | 81 | 0.480 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 524 | 0.470 |
Why?
|
| Adolescent | 11 | 2018 | 3638 | 0.470 |
Why?
|
| Porosity | 6 | 2020 | 39 | 0.470 |
Why?
|
| Treatment Outcome | 12 | 2021 | 3438 | 0.460 |
Why?
|
| Chondrogenesis | 2 | 2015 | 20 | 0.460 |
Why?
|
| Endoscopy | 2 | 2021 | 56 | 0.450 |
Why?
|
| Virus Integration | 1 | 2014 | 5 | 0.450 |
Why?
|
| Male Urogenital Diseases | 1 | 2014 | 4 | 0.450 |
Why?
|
| Cell Survival | 7 | 2020 | 280 | 0.440 |
Why?
|
| MicroRNAs | 3 | 2023 | 188 | 0.440 |
Why?
|
| Umbilical Cord | 5 | 2023 | 8 | 0.430 |
Why?
|
| Aged | 15 | 2020 | 10538 | 0.430 |
Why?
|
| Detergents | 1 | 2014 | 16 | 0.420 |
Why?
|
| Fistula | 1 | 2014 | 11 | 0.420 |
Why?
|
| Child, Preschool | 8 | 2018 | 1282 | 0.420 |
Why?
|
| Immunohistochemistry | 10 | 2019 | 497 | 0.410 |
Why?
|
| Cell Adhesion | 4 | 2019 | 103 | 0.410 |
Why?
|
| Cone-Beam Computed Tomography | 3 | 2018 | 20 | 0.400 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 107 | 0.400 |
Why?
|
| Muscles | 1 | 2013 | 63 | 0.400 |
Why?
|
| Tissue Preservation | 1 | 2013 | 8 | 0.400 |
Why?
|
| Prostatic Hyperplasia | 3 | 2019 | 44 | 0.380 |
Why?
|
| Telomerase | 4 | 2019 | 20 | 0.380 |
Why?
|
| Appendiceal Neoplasms | 1 | 2014 | 98 | 0.380 |
Why?
|
| Blotting, Western | 4 | 2019 | 287 | 0.380 |
Why?
|
| Polyesters | 2 | 2012 | 78 | 0.370 |
Why?
|
| Neurotoxins | 1 | 2012 | 15 | 0.370 |
Why?
|
| Ureteral Calculi | 1 | 2012 | 7 | 0.370 |
Why?
|
| Stomach | 1 | 2012 | 17 | 0.370 |
Why?
|
| Ceftriaxone | 1 | 2012 | 15 | 0.370 |
Why?
|
| Chitosan | 1 | 2011 | 3 | 0.360 |
Why?
|
| Nanofibers | 1 | 2011 | 7 | 0.360 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 38 | 0.360 |
Why?
|
| Dogs | 6 | 2014 | 120 | 0.360 |
Why?
|
| Nanostructures | 2 | 2020 | 21 | 0.350 |
Why?
|
| Regenerative Medicine | 2 | 2019 | 202 | 0.350 |
Why?
|
| Cell Transplantation | 4 | 2013 | 64 | 0.350 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 300 | 0.350 |
Why?
|
| Pregnancy | 4 | 2023 | 981 | 0.350 |
Why?
|
| Transplantation, Autologous | 3 | 2017 | 84 | 0.340 |
Why?
|
| Cellulose | 1 | 2010 | 2 | 0.340 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 726 | 0.330 |
Why?
|
| Urinary Diversion | 1 | 2010 | 27 | 0.330 |
Why?
|
| Smad Proteins | 2 | 2020 | 7 | 0.330 |
Why?
|
| Stromal Cells | 2 | 2013 | 67 | 0.330 |
Why?
|
| Delayed-Action Preparations | 3 | 2020 | 36 | 0.320 |
Why?
|
| Penile Erection | 3 | 2020 | 21 | 0.310 |
Why?
|
| Azoospermia | 3 | 2019 | 7 | 0.300 |
Why?
|
| Diabetes Complications | 3 | 2016 | 182 | 0.300 |
Why?
|
| Kidney Tubules | 2 | 2019 | 26 | 0.300 |
Why?
|
| Tight Junctions | 2 | 2018 | 10 | 0.290 |
Why?
|
| Penis | 3 | 2020 | 35 | 0.290 |
Why?
|
| Cell Lineage | 3 | 2014 | 71 | 0.290 |
Why?
|
| Urethral Stricture | 3 | 2021 | 31 | 0.290 |
Why?
|
| Gene Expression | 3 | 2019 | 334 | 0.280 |
Why?
|
| Tensile Strength | 4 | 2014 | 56 | 0.280 |
Why?
|
| Nerve Growth Factors | 2 | 2018 | 14 | 0.280 |
Why?
|
| Serpins | 2 | 2018 | 6 | 0.280 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2018 | 57 | 0.270 |
Why?
|
| Apoptosis | 6 | 2019 | 362 | 0.270 |
Why?
|
| Eye Proteins | 2 | 2018 | 36 | 0.270 |
Why?
|
| Fibroblasts | 4 | 2017 | 114 | 0.270 |
Why?
|
| Creatinine | 3 | 2019 | 198 | 0.260 |
Why?
|
| Oxidative Stress | 5 | 2020 | 239 | 0.260 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 37 | 0.250 |
Why?
|
| RNA | 2 | 2019 | 87 | 0.250 |
Why?
|
| Organ Specificity | 3 | 2017 | 80 | 0.250 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 316 | 0.240 |
Why?
|
| Skin | 2 | 2023 | 214 | 0.240 |
Why?
|
| Infant | 4 | 2018 | 1083 | 0.240 |
Why?
|
| Cystectomy | 1 | 2006 | 106 | 0.240 |
Why?
|
| Adenoviridae | 2 | 2018 | 68 | 0.240 |
Why?
|
| Rats, Nude | 3 | 2020 | 43 | 0.230 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2020 | 94 | 0.230 |
Why?
|
| Cystitis, Interstitial | 2 | 2017 | 53 | 0.220 |
Why?
|
| X-Ray Microtomography | 2 | 2015 | 41 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 6 | 2020 | 169 | 0.210 |
Why?
|
| Nanocapsules | 2 | 2014 | 4 | 0.210 |
Why?
|
| Sulfur | 1 | 2023 | 4 | 0.200 |
Why?
|
| Submandibular Gland | 2 | 2020 | 4 | 0.200 |
Why?
|
| Desmin | 2 | 2013 | 12 | 0.200 |
Why?
|
| Salivary Glands | 2 | 2020 | 14 | 0.200 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 220 | 0.200 |
Why?
|
| Culture Media | 2 | 2019 | 45 | 0.200 |
Why?
|
| Cisplatin | 2 | 2020 | 81 | 0.190 |
Why?
|
| Down-Regulation | 3 | 2020 | 134 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2014 | 498 | 0.190 |
Why?
|
| Acute Disease | 2 | 2020 | 259 | 0.190 |
Why?
|
| Genetic Vectors | 4 | 2017 | 120 | 0.190 |
Why?
|
| Plasmids | 2 | 2022 | 45 | 0.190 |
Why?
|
| Cell Membrane | 2 | 2014 | 96 | 0.190 |
Why?
|
| Antioxidants | 2 | 2020 | 115 | 0.180 |
Why?
|
| Cell Division | 2 | 2001 | 94 | 0.180 |
Why?
|
| Octoxynol | 2 | 2014 | 6 | 0.180 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 4032 | 0.180 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 113 | 0.180 |
Why?
|
| Prostatectomy | 2 | 2020 | 83 | 0.180 |
Why?
|
| Spermatogenesis | 2 | 2019 | 47 | 0.180 |
Why?
|
| Guided Tissue Regeneration | 2 | 2014 | 38 | 0.180 |
Why?
|
| Urography | 2 | 2019 | 15 | 0.170 |
Why?
|
| Muscle Contraction | 3 | 2010 | 113 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 15 | 0.170 |
Why?
|
| Time Factors | 5 | 2019 | 2183 | 0.170 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 563 | 0.170 |
Why?
|
| Pelvic Bones | 1 | 2021 | 34 | 0.170 |
Why?
|
| Synapses | 2 | 2011 | 83 | 0.170 |
Why?
|
| Models, Biological | 2 | 2020 | 392 | 0.170 |
Why?
|
| Brain Injuries | 2 | 2011 | 91 | 0.170 |
Why?
|
| Aneurysm, Dissecting | 1 | 2020 | 12 | 0.170 |
Why?
|
| Drug Combinations | 2 | 2018 | 99 | 0.160 |
Why?
|
| Colitis | 1 | 2020 | 7 | 0.160 |
Why?
|
| Dinoprostone | 1 | 2020 | 31 | 0.160 |
Why?
|
| Fibroins | 1 | 2020 | 5 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 38 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2020 | 29 | 0.160 |
Why?
|
| Th1 Cells | 1 | 2020 | 25 | 0.160 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 22 | 0.160 |
Why?
|
| Phenanthrenes | 1 | 2020 | 3 | 0.160 |
Why?
|
| Materials Testing | 2 | 2011 | 92 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 29 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 17 | 0.160 |
Why?
|
| Spermatic Cord Torsion | 1 | 2020 | 2 | 0.160 |
Why?
|
| Trauma, Nervous System | 1 | 2020 | 9 | 0.160 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2019 | 1 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 90 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2020 | 10 | 0.160 |
Why?
|
| Adiponectin | 1 | 2020 | 103 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2020 | 19 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2020 | 191 | 0.160 |
Why?
|
| Cell Membrane Permeability | 2 | 2018 | 18 | 0.160 |
Why?
|
| Neoplasms | 2 | 2017 | 761 | 0.160 |
Why?
|
| Paracrine Communication | 1 | 2019 | 6 | 0.160 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 49 | 0.160 |
Why?
|
| Kidney Glomerulus | 2 | 2016 | 30 | 0.160 |
Why?
|
| Recovery of Function | 3 | 2020 | 203 | 0.150 |
Why?
|
| Cryptorchidism | 1 | 2019 | 3 | 0.150 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 56 | 0.150 |
Why?
|
| Mucin-1 | 1 | 2019 | 11 | 0.150 |
Why?
|
| Infertility | 1 | 2019 | 14 | 0.150 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2019 | 2 | 0.150 |
Why?
|
| DNA Transposable Elements | 2 | 2017 | 13 | 0.150 |
Why?
|
| Keloid | 1 | 2019 | 8 | 0.150 |
Why?
|
| Tretinoin | 1 | 2019 | 33 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 57 | 0.150 |
Why?
|
| Prostatism | 1 | 2019 | 3 | 0.150 |
Why?
|
| Epidermis | 1 | 2019 | 29 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 115 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 105 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2020 | 87 | 0.150 |
Why?
|
| Periodontal Ligament | 2 | 2019 | 2 | 0.150 |
Why?
|
| Bone Regeneration | 2 | 2016 | 33 | 0.150 |
Why?
|
| Angiogenic Proteins | 1 | 2018 | 10 | 0.140 |
Why?
|
| Laminin | 1 | 2018 | 13 | 0.140 |
Why?
|
| Antigens, Surface | 1 | 2018 | 24 | 0.140 |
Why?
|
| Proteoglycans | 1 | 2018 | 29 | 0.140 |
Why?
|
| Biological Therapy | 1 | 2018 | 20 | 0.140 |
Why?
|
| Keratins | 2 | 2013 | 37 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 142 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2018 | 39 | 0.140 |
Why?
|
| Collagen Type III | 1 | 2018 | 8 | 0.140 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 80 | 0.140 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 10 | 0.140 |
Why?
|
| Adipogenesis | 4 | 2020 | 30 | 0.140 |
Why?
|
| Ameloblastoma | 1 | 2018 | 1 | 0.140 |
Why?
|
| Jaw Neoplasms | 1 | 2018 | 1 | 0.140 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2018 | 17 | 0.140 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1998 | 5 | 0.140 |
Why?
|
| Histiocytosis, Sinus | 1 | 2018 | 3 | 0.140 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 4 | 0.140 |
Why?
|
| Maxillary Fractures | 1 | 2018 | 4 | 0.140 |
Why?
|
| Maxilla | 1 | 2018 | 10 | 0.140 |
Why?
|
| Nephritis, Interstitial | 1 | 2018 | 9 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 526 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 384 | 0.140 |
Why?
|
| Oligopeptides | 1 | 2018 | 43 | 0.140 |
Why?
|
| Maxillofacial Injuries | 1 | 2018 | 9 | 0.140 |
Why?
|
| Burns | 1 | 2019 | 100 | 0.140 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 241 | 0.140 |
Why?
|
| Ureteroscopy | 2 | 2015 | 6 | 0.140 |
Why?
|
| Inflammation | 2 | 2020 | 536 | 0.140 |
Why?
|
| Protein Binding | 1 | 2018 | 200 | 0.140 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 27 | 0.140 |
Why?
|
| Doxorubicin | 2 | 2015 | 83 | 0.140 |
Why?
|
| Hexuronic Acids | 1 | 2017 | 31 | 0.140 |
Why?
|
| Glucuronic Acid | 1 | 2017 | 31 | 0.140 |
Why?
|
| Gelatin | 1 | 2017 | 29 | 0.130 |
Why?
|
| Transfection | 4 | 2022 | 184 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 881 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 94 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2017 | 176 | 0.130 |
Why?
|
| Alginates | 1 | 2017 | 52 | 0.130 |
Why?
|
| Varicocele | 1 | 2017 | 3 | 0.130 |
Why?
|
| Carcinoma | 1 | 2018 | 92 | 0.130 |
Why?
|
| Urethral Diseases | 1 | 2017 | 17 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 24 | 0.130 |
Why?
|
| Microsurgery | 1 | 2017 | 21 | 0.130 |
Why?
|
| Radiography, Dental | 1 | 2016 | 2 | 0.130 |
Why?
|
| Malocclusion | 1 | 2016 | 5 | 0.130 |
Why?
|
| Embolism | 1 | 2016 | 7 | 0.130 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 599 | 0.130 |
Why?
|
| Podocytes | 1 | 2016 | 20 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 18 | 0.130 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 30 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 44 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 475 | 0.130 |
Why?
|
| Wilms Tumor | 1 | 2016 | 14 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 61 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 1462 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 40 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 297 | 0.130 |
Why?
|
| Elastic Modulus | 2 | 2020 | 27 | 0.120 |
Why?
|
| Benzylisoquinolines | 1 | 2016 | 1 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 84 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 98 | 0.120 |
Why?
|
| Thrombosis | 1 | 2017 | 81 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2017 | 105 | 0.120 |
Why?
|
| Bone Substitutes | 1 | 2016 | 9 | 0.120 |
Why?
|
| Sus scrofa | 2 | 2017 | 47 | 0.120 |
Why?
|
| Heart Atria | 1 | 2016 | 78 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 35 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 767 | 0.120 |
Why?
|
| Postoperative Complications | 3 | 2020 | 828 | 0.120 |
Why?
|
| Dental Sac | 1 | 2015 | 1 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 76 | 0.120 |
Why?
|
| Semen | 1 | 2015 | 10 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 154 | 0.120 |
Why?
|
| Hormones | 1 | 2015 | 20 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2015 | 14 | 0.110 |
Why?
|
| Root Resorption | 1 | 2015 | 1 | 0.110 |
Why?
|
| Tooth Root | 1 | 2015 | 1 | 0.110 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 14 | 0.110 |
Why?
|
| Surgical Flaps | 2 | 2014 | 77 | 0.110 |
Why?
|
| Particle Size | 2 | 2018 | 47 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2018 | 403 | 0.110 |
Why?
|
| Lithotripsy | 1 | 2015 | 12 | 0.110 |
Why?
|
| Kidney Calculi | 1 | 2015 | 23 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 91 | 0.110 |
Why?
|
| Proteins | 2 | 2014 | 142 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 193 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 789 | 0.110 |
Why?
|
| Furcation Defects | 1 | 2014 | 1 | 0.110 |
Why?
|
| Alveolar Bone Loss | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ultrasonic Therapy | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sound | 1 | 2014 | 3 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2014 | 17 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 17 | 0.110 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2014 | 3 | 0.110 |
Why?
|
| Trypsin | 1 | 2014 | 11 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 42 | 0.110 |
Why?
|
| Pericytes | 2 | 2013 | 33 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 64 | 0.110 |
Why?
|
| Glycosaminoglycans | 1 | 2014 | 20 | 0.110 |
Why?
|
| Cartilage | 1 | 2014 | 31 | 0.110 |
Why?
|
| Diterpenes | 1 | 2013 | 17 | 0.100 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 30 | 0.100 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2013 | 16 | 0.100 |
Why?
|
| Clone Cells | 1 | 2013 | 35 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 88 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 145 | 0.100 |
Why?
|
| Chondrocytes | 1 | 2014 | 69 | 0.100 |
Why?
|
| Myoblasts, Skeletal | 1 | 2013 | 19 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 112 | 0.100 |
Why?
|
| Myosins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2013 | 1 | 0.100 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2013 | 8 | 0.100 |
Why?
|
| Polyps | 1 | 2013 | 9 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 80 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Ureteral Neoplasms | 1 | 2013 | 11 | 0.100 |
Why?
|
| Lasers, Solid-State | 1 | 2012 | 8 | 0.100 |
Why?
|
| Microspheres | 1 | 2012 | 44 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 213 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 222 | 0.100 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2012 | 17 | 0.090 |
Why?
|
| Hypertension | 2 | 2016 | 976 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2012 | 51 | 0.090 |
Why?
|
| Centrifugation | 1 | 2012 | 3 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2018 | 35 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 13 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 97 | 0.090 |
Why?
|
| Bioprosthesis | 1 | 2012 | 61 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 1 | 2012 | 27 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2012 | 58 | 0.090 |
Why?
|
| Polymers | 1 | 2012 | 66 | 0.090 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2023 | 9 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 152 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 576 | 0.090 |
Why?
|
| Synaptophysin | 1 | 2011 | 2 | 0.090 |
Why?
|
| GAP-43 Protein | 1 | 2011 | 6 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2011 | 79 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 37 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 117 | 0.080 |
Why?
|
| Acetobacter | 1 | 2010 | 2 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 456 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 349 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 39 | 0.080 |
Why?
|
| Endotoxins | 1 | 2010 | 37 | 0.080 |
Why?
|
| Synovial Membrane | 1 | 2010 | 6 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 428 | 0.080 |
Why?
|
| Absorption | 1 | 2009 | 15 | 0.080 |
Why?
|
| Crystallization | 1 | 2009 | 17 | 0.080 |
Why?
|
| Menisci, Tibial | 1 | 2010 | 23 | 0.080 |
Why?
|
| Surface Properties | 1 | 2009 | 36 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 77 | 0.080 |
Why?
|
| Keratinocytes | 1 | 2009 | 29 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 18 | 0.080 |
Why?
|
| Biomimetic Materials | 1 | 2009 | 15 | 0.080 |
Why?
|
| Spermatozoa | 2 | 2019 | 28 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2008 | 44 | 0.070 |
Why?
|
| Protamines | 2 | 2019 | 4 | 0.070 |
Why?
|
| Cytokines | 2 | 2020 | 247 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2019 | 20 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2009 | 251 | 0.070 |
Why?
|
| Cell Line | 2 | 2020 | 433 | 0.070 |
Why?
|
| Ionophores | 2 | 2005 | 3 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 238 | 0.070 |
Why?
|
| Muscle Proteins | 2 | 2019 | 63 | 0.070 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 69 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 163 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2284 | 0.070 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 64 | 0.070 |
Why?
|
| Busulfan | 2 | 2019 | 4 | 0.070 |
Why?
|
| Sheep | 2 | 1998 | 233 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2018 | 83 | 0.070 |
Why?
|
| Cadherins | 2 | 2018 | 27 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2018 | 240 | 0.060 |
Why?
|
| Transplantation, Heterologous | 2 | 2017 | 122 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2008 | 876 | 0.060 |
Why?
|
| Calcimycin | 1 | 2005 | 6 | 0.060 |
Why?
|
| Biopsy | 2 | 2018 | 245 | 0.060 |
Why?
|
| Femur | 1 | 2005 | 79 | 0.060 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2016 | 21 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2005 | 25 | 0.060 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2004 | 18 | 0.050 |
Why?
|
| Foreskin | 2 | 2017 | 8 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 1544 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2023 | 3 | 0.050 |
Why?
|
| Mucins | 1 | 2023 | 17 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2023 | 26 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2023 | 5 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2023 | 8 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2003 | 21 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2022 | 1 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 205 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 71 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2022 | 42 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 100 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 14 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 16 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2020 | 4 | 0.040 |
Why?
|
| Limbus Corneae | 1 | 2020 | 7 | 0.040 |
Why?
|
| Aristolochic Acids | 1 | 2020 | 2 | 0.040 |
Why?
|
| Phytohemagglutinins | 1 | 2020 | 1 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 1 | 0.040 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2020 | 2 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2009 | 694 | 0.040 |
Why?
|
| Metals | 1 | 2020 | 17 | 0.040 |
Why?
|
| Hydrogen Sulfide | 1 | 2020 | 3 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2020 | 50 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2020 | 25 | 0.040 |
Why?
|
| Phototherapy | 1 | 2020 | 51 | 0.040 |
Why?
|
| Hypogastric Plexus | 1 | 2020 | 8 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2019 | 13 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2019 | 18 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 3701 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2019 | 24 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 89 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 226 | 0.040 |
Why?
|
| Fibronectins | 1 | 2019 | 37 | 0.040 |
Why?
|
| Xerostomia | 1 | 2019 | 30 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 9 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 65 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 84 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2019 | 18 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2019 | 36 | 0.040 |
Why?
|
| Blood-Testis Barrier | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sperm Count | 1 | 2019 | 2 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 57 | 0.040 |
Why?
|
| Flutamide | 1 | 2019 | 4 | 0.040 |
Why?
|
| Pelvis | 1 | 2020 | 64 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 7 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 3 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 240 | 0.040 |
Why?
|
| Bioreactors | 1 | 2019 | 61 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 56 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 135 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 104 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 267 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 94 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2018 | 17 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2020 | 125 | 0.040 |
Why?
|
| Actins | 1 | 2018 | 51 | 0.040 |
Why?
|
| Prostate | 1 | 2019 | 69 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 486 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 12 | 0.040 |
Why?
|
| Tooth | 1 | 2018 | 2 | 0.040 |
Why?
|
| Glycine | 1 | 2018 | 27 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1998 | 14 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2018 | 24 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1998 | 30 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 40 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 43 | 0.030 |
Why?
|
| Mandible | 1 | 2018 | 39 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 48 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2017 | 2 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 32 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 18 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 84 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 18 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 114 | 0.030 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2017 | 42 | 0.030 |
Why?
|
| Sendai virus | 1 | 2017 | 1 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 16 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2017 | 16 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 28 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 28 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 107 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 71 | 0.030 |
Why?
|
| Tooth Loss | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
| Neuroglia | 1 | 2017 | 29 | 0.030 |
Why?
|
| Periodontitis | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tomography | 1 | 2016 | 5 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 115 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 59 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 255 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 6 | 0.030 |
Why?
|
| DNA | 1 | 2017 | 218 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 76 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 470 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 512 | 0.030 |
Why?
|
| Dextrans | 1 | 2015 | 3 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2015 | 18 | 0.030 |
Why?
|
| Proteinuria | 1 | 1995 | 55 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 1995 | 43 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 71 | 0.030 |
Why?
|
| Myocardium | 1 | 2016 | 191 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 2014 | 6 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 6 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 9 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 36 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 894 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 14 | 0.030 |
Why?
|
| Spermatogonia | 1 | 2014 | 14 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 90 | 0.030 |
Why?
|
| Nanocomposites | 1 | 2014 | 6 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2014 | 25 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2014 | 50 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 151 | 0.030 |
Why?
|
| Nocturia | 1 | 2013 | 1 | 0.030 |
Why?
|
| Publication Bias | 1 | 2013 | 8 | 0.030 |
Why?
|
| Random Allocation | 1 | 2014 | 229 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 2013 | 23 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2014 | 67 | 0.030 |
Why?
|
| Urination | 1 | 2013 | 16 | 0.030 |
Why?
|
| Urodynamics | 1 | 2013 | 36 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 8 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 459 | 0.030 |
Why?
|
| Peptides | 1 | 2014 | 125 | 0.030 |
Why?
|
| Urinary Incontinence | 1 | 2013 | 48 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 511 | 0.030 |
Why?
|
| Neurons | 1 | 2017 | 416 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1238 | 0.020 |
Why?
|
| Prolapse | 1 | 2013 | 5 | 0.020 |
Why?
|
| Dysuria | 1 | 2012 | 1 | 0.020 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2012 | 8 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 42 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2013 | 356 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1307 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 171 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 301 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2012 | 136 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 47 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 494 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 126 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2009 | 10 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 32 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2011 | 253 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 51 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 327 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 565 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 2327 | 0.020 |
Why?
|
| Permeability | 1 | 2005 | 9 | 0.010 |
Why?
|
| Elasticity | 1 | 2005 | 38 | 0.010 |
Why?
|
| Urea | 1 | 2005 | 37 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 3974 | 0.010 |
Why?
|
| Keratin-20 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 2000 | 11 | 0.010 |
Why?
|
| Integrins | 1 | 2000 | 15 | 0.010 |
Why?
|
| Karyotyping | 1 | 1999 | 28 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 1999 | 24 | 0.010 |
Why?
|
| Calcium | 1 | 1999 | 323 | 0.010 |
Why?
|